36th Euro Global Summit and Expo on Vaccines & Vaccination
Valneva Austria GmbH, Austria
Dr. Andrea Fritzer is currently Senior Scientist at Valneva Austria GmbH, which is a fully integrated, commercial stage biotech company, focused on developing innovative and life-saving vaccines. Andrea has gained in her 13 years working in the field of biotechnology and vaccine research, a broad and solid background in molecular biology, bacteriology, virology and immunology. Additionally, she has worked in the field of therapeutic monoclonal antibody discovery and antibody engineering. Her primary function at Valneva is to coordinate various projects advancing them from preclinical development into clinical studies with focus not only on in vitro assay development but also on the initiation and continuation of research collaborations. Valneva’s chikungunya vaccine VLA1553 is currently her main project where she is supporting the progress of VLA1553 to enter the next clinical phase.